Merit Financial Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
3,441
-2,952
| -46% | -$1.15M | 0.01% | 655 |
|
|
2025
Q1 | $2.78M | Buy |
6,393
+2,975
| +87% | +$1.29M | 0.04% | 341 |
|
|
2024
Q4 | $1.26M | Buy |
3,418
+192
| +6% | +$70.8K | 0.02% | 446 |
|
|
2024
Q3 | $1.68M | Sell |
3,226
-318
| -9% | -$165K | 0.04% | 304 |
|
|
2024
Q2 | $1.92M | Buy |
3,544
+66
| +2% | +$35.8K | 0.04% | 274 |
|
|
2024
Q1 | $1.83M | Buy |
3,478
+1,614
| +87% | +$850K | 0.04% | 275 |
|
|
2023
Q4 | $879K | Sell |
1,864
-926
| -33% | -$437K | 0.03% | 345 |
|
|
2023
Q3 | $1.21M | Buy |
2,790
+99
| +4% | +$43.1K | 0.04% | 292 |
|
|
2023
Q2 | $1.2M | Buy |
2,691
+978
| +57% | +$434K | 0.04% | 302 |
|
|
2023
Q1 | $788K | Buy |
1,713
+403
| +31% | +$185K | 0.03% | 318 |
|
|
2022
Q4 | $672K | Buy |
1,310
+70
| +6% | +$35.9K | 0.02% | 364 |
|
|
2022
Q3 | $563K | Sell |
1,240
-91
| -7% | -$41.3K | 0.02% | 334 |
|
|
2022
Q2 | $642K | Buy |
1,331
+813
| +157% | +$392K | 0.02% | 308 |
|
|
2022
Q1 | $254K | Buy |
518
+33
| +7% | +$16.2K | 0.02% | 322 |
|
|
2021
Q4 | $225K | Buy |
+485
| New | +$225K | 0.02% | 253 |
|